Suppr超能文献

[MEP - 28] 胸主动脉移动性血栓的优化管理:临床病例经验教训

[MEP-28] Optimal Management of Thoracic Aortic Mobile Thrombus: Lessons From Clinical Cases.

作者信息

Civelek İsa, Emir Erol Mehmet, Özyalçın Sertan, İnce İlker

机构信息

Department of Cardiovascular Surgery, Etlik City Hospital, Ankara, Türkiye.

出版信息

Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Dec 31;32(4 Suppl 2):125-126. doi: 10.5606/tgkdc.dergisi.2024.mep-28. eCollection 2024 Nov.

Abstract

Thoracic aortic mobile thrombus (TAMT) is a rare and potentially life-threatening condition, often detected due to thromboembolic events. Early diagnosis has improved with advanced imaging modalities such as computed tomography and magnetic resonance imaging. However, no definitive treatment algorithm exists; options include medical management, hybrid approaches, endovascular therapy, and open surgery. This report discussed options in two TAMT patients at our center. In the first case, a 59-year-old female with diabetes and hypertension presented with back and flank pain. Computed tomography angiography revealed a 5.5-cm descending aortic thrombus, with additional splenic and renal infarcts. Emergency thoracic endovascular aortic repair was performed, successfully excluding the thrombus with no embolic events. The patient was discharged on anticoagulants and remained asymptomatic on follow-up. In the second case, a 44-year-old male without comorbidities presented with abdominal pain. Computed tomography angiography showed five descending aortic thrombi, with infarcts in the spleen and kidney. Catheter-directed thrombolysis was performed using alteplase. All thrombi lysed without complications, and the patient was discharged on anticoagulants. Followup imaging showed no residual thrombi. Thoracic aortic mobile thrombi can lead to severe complications, including systemic embolization and organ failure. Risk factors include hypercoagulability and conditions such as hypertension and diabetes. Treatment must be individualized based on thrombus location, patient condition, and center expertise. In our cases, thoracic endovascular aortic repair was chosen for a localized thrombus, while multilocation thrombi were managed with thrombolysis. Thrombolytic therapy requires careful monitoring of fibrinogen levels to minimize bleeding risk. With no current guideline directions, treatment should be tailored to the patient by weighing the risks and benefits of interventions based on individual patient factors and institutional resources.

摘要

胸主动脉移动性血栓(TAMT)是一种罕见且可能危及生命的疾病,常因血栓栓塞事件而被发现。随着计算机断层扫描和磁共振成像等先进成像方式的出现,早期诊断有所改善。然而,目前尚无明确的治疗方案;治疗选择包括药物治疗、混合治疗、血管内治疗和开放手术。本报告讨论了我们中心两名TAMT患者的治疗选择。在第一个病例中,一名患有糖尿病和高血压的59岁女性出现背部和侧腹疼痛。计算机断层扫描血管造影显示降主动脉有一个5.5厘米的血栓,伴有脾脏和肾脏梗死。进行了急诊胸主动脉血管内修复术,成功排除了血栓,未发生栓塞事件。患者出院时服用抗凝剂,随访期间无症状。在第二个病例中,一名无合并症的44岁男性出现腹痛。计算机断层扫描血管造影显示降主动脉有五个血栓,伴有脾脏和肾脏梗死。使用阿替普酶进行了导管定向溶栓治疗。所有血栓均溶解,无并发症发生,患者出院时服用抗凝剂。随访成像显示无残留血栓。胸主动脉移动性血栓可导致严重并发症,包括全身栓塞和器官衰竭。危险因素包括高凝状态以及高血压和糖尿病等疾病。治疗必须根据血栓位置、患者状况和中心专业知识进行个体化。在我们的病例中,对于局限性血栓选择了胸主动脉血管内修复术,而对于多处血栓则采用溶栓治疗。溶栓治疗需要仔细监测纤维蛋白原水平,以将出血风险降至最低。由于目前没有指南指导,应根据个体患者因素和机构资源权衡干预措施的风险和益处,为患者量身定制治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc60/12045169/96a82b3daa7d/TJTCS-2024-11-100-125-126-F1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验